XTLB Stock Analysis: Buy, Sell, or Hold?
XTLB - XTL Biopharmaceuticals Ltd. American Depositary Shares
$2.77
-0.05 (-1.77%)
▼
5d:
-3.82%
30d:
+2.59%
90d:
-24.11%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Apr 29, 2026
0d
Get Alerted When XTLB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: XTLB shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: XTLB shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: XTLB is currently trading at $2.77, which is considered fair relative to its 30-day fair value range of $2.64 to $3.01.
Technical Outlook: Technically, XTLB is in a uptrend. Immediate support is located at $2.50, while resistance sits at $2.98.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+963.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XTLB is in a uptrend. Immediate support is located at $2.50, while resistance sits at $2.98.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+963.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.64 -
$3.01
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 963.8% below Wall St target ($30.00)
Trading Range Analysis
30-Day Trading Range
$2.64 -
$3.01
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.50
Resistance Level
$2.98
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Wall Street Target
$30.00
(+963.8%)
Earnings Growth (YoY)
-76.0%
Share & Embed Analysis
Last updated: August 03, 2026 3:12 PM ET
Data refreshes hourly during market hours. Next update: 4:12 PM
Data refreshes hourly during market hours. Next update: 4:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XTLB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 53 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$386 | 43 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 49 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 54 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$57 | 57 HOLD |